JAK2 inhibitors for myeloproliferative neoplasms: what is next? [electronic resource]
Producer: 20170815Description: 115-125 p. digitalISSN:- 1528-0020
- Antineoplastic Agents -- therapeutic use
- Bridged-Ring Compounds -- therapeutic use
- Gene Expression
- Humans
- Janus Kinase 1 -- antagonists & inhibitors
- Janus Kinase 2 -- antagonists & inhibitors
- Mutation
- Nitriles
- Patient Safety
- Polycythemia Vera -- drug therapy
- Primary Myelofibrosis -- drug therapy
- Protein Kinase Inhibitors -- therapeutic use
- Pyrazoles -- therapeutic use
- Pyrimidines -- therapeutic use
- Randomized Controlled Trials as Topic
- Thrombocythemia, Essential -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.